How do I complete the primary series with PEDIARIX following DTaP from another manufacturer?
It is recommended that PEDIARIX be given for all 3 doses because data are limited regarding the safety and efficacy of using acellular pertussis vaccines from different manufacturers for successive doses of the pertussis vaccination series. PEDIARIX is not recommended for completion of the 3-dose infant DTaP vaccination series initiated with a DTaP vaccine from a different manufacturer because no data are available regarding the efficacy of using such a regimen. [1] The ACIP/AAP/AAFP recommend that immunization providers who cannot determine which DTaP vaccine was previously administered, or who do not have the same vaccine, should use any of the licensed acellular pertussis products to continue the immunization series.
